The solid progress of nanomedicine

João Pedro Martins; José das Neves; María de la Fuente; Christian Celia; Helena Florindo; Nazende Günday-Türeli; Amirali Popat; José Luis Santos; Flávia Sousa; Ruth Schmid; Joy Wolfram; Bruno Sarmento; Hélder A. Santos

doi:10.1007/s13346-020-00743-2

The solid progress of nanomedicine

João Pedro Martins, José das Neves, María de la Fuente, Christian Celia, Helena Florindo, Nazende Günday-Türeli, Amirali Popat, José Luis Santos, Flávia Sousa, Ruth Schmid, Joy Wolfram, Bruno Sarmento, Hélder A. Santos

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. [Figure not available: see fulltext.].

Original language	English (US)
Pages (from-to)	726-729
Number of pages	4
Journal	Drug Delivery and Translational Research
Volume	10
Issue number	3
DOIs	https://doi.org/10.1007/s13346-020-00743-2
State	Published - Jun 1 2020

Keywords

Cancer therapy
Clinical translation
Nanomedicine
Nanotechnology
Reproducibility

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.1007/s13346-020-00743-2

Cite this

@article{7707599e0e414446bdff39513fda7039,

title = "The solid progress of nanomedicine",

abstract = "This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. [Figure not available: see fulltext.].",

keywords = "Cancer therapy, Clinical translation, Nanomedicine, Nanotechnology, Reproducibility",

author = "Martins, {Jo{\~a}o Pedro} and {das Neves}, Jos{\'e} and {de la Fuente}, Mar{\'i}a and Christian Celia and Helena Florindo and Nazende G{\"u}nday-T{\"u}reli and Amirali Popat and Santos, {Jos{\'e} Luis} and Fl{\'a}via Sousa and Ruth Schmid and Joy Wolfram and Bruno Sarmento and Santos, {H{\'e}lder A.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = jun,

day = "1",

doi = "10.1007/s13346-020-00743-2",

language = "English (US)",

volume = "10",

pages = "726--729",

journal = "Drug Delivery and Translational Research",

issn = "2190-393X",

publisher = "Springer Publishing Company",

number = "3",

}

TY - JOUR

T1 - The solid progress of nanomedicine

AU - Martins, João Pedro

AU - das Neves, José

AU - de la Fuente, María

AU - Celia, Christian

AU - Florindo, Helena

AU - Günday-Türeli, Nazende

AU - Popat, Amirali

AU - Santos, José Luis

AU - Sousa, Flávia

AU - Schmid, Ruth

AU - Wolfram, Joy

AU - Sarmento, Bruno

AU - Santos, Hélder A.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. [Figure not available: see fulltext.].

AB - This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. [Figure not available: see fulltext.].

KW - Cancer therapy

KW - Clinical translation

KW - Nanomedicine

KW - Nanotechnology

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=85081606697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081606697&partnerID=8YFLogxK

U2 - 10.1007/s13346-020-00743-2

DO - 10.1007/s13346-020-00743-2

M3 - Article

C2 - 32141035

AN - SCOPUS:85081606697

SN - 2190-393X

VL - 10

SP - 726

EP - 729

JO - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

IS - 3

ER -

The solid progress of nanomedicine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this